2BB score and signals
Dogwood Therapeutics, Inc.’s current 2BB score is 17 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 2 | Very Low |
| Momentum | 50 | Stable |
| Financial strength | 46 | Normal |
| Quality | 20 | Weak |
| Risk | 73 | High |
Company facts
| Headquarters | Alpharetta, Georgia, United States |
| Founded | 2012 |
| Employees | 8 |
| 52-week range | $1.24 – $7.04 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2027-03-16 | — | -0.1632 | — | — |
| 2026-11-04 | — | -0.1581 | — | — |
| 2026-08-11 | — | -0.1428 | — | $0.00 |
| 2026-05-14 | -0.15 | -0.2618 | $0.00 | $0.00 |
Related companies
